Cancer Diagnostics
Receive regular headline summaries whenever high-quality news is generated for Cancer Diagnostics. We'll never share your email address with others.
Selected Headlines
| Date | Headline (link) | Source | Relevant Snippet |
|---|---|---|---|
| 7/19/2021 | Global Lung Cancer Diagnostics Market to Reach US$4.3 Billion by the Year 2027 | Globe Newswire | New York, July 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lung Cancer Diagnostics Industry" - https://www.reportlinker.com/p05834219/?utm_source=GNW 5 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027.Imaging Tests, one of the segments analyzed in the report, is projected to grow at ... |
| 7/19/2021 | Global Lung Cancer Diagnostics Market to Reach US$4.3 Billion by the Year 2027 | Yahoo News | Abstract: Global Lung Cancer Diagnostics Market to Reach US$4. 3 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Lung Cancer Diagnostics estimated at US$2.New York, July 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Lung Cancer Diagnostics Industry" - https://www.reportlinker.com/p05834219/?utm_source=GNW5 Billion in the year 2020, is projected to reach a revised size ... |
| 7/6/2021 | ACT Genomics Completes Acquisition of MC Diagnostics | scoopasia.com | ... manufactured an automated low density array platform ("ALDAS"), which is currently providing proven clinical diagnostic assays in the fields of HLA typing and blood group diagnostics. Revolutionary Breakthrough in Genechip Technology Effective and affordable cancer diagnostics testing tools with quick turnaround time and high sensitivity have always been sought after in the market. As a company at the forefront of Next Generation Sequencing (NGS) molecular diagnostics in the field of ... |
| 7/6/2021 | ACT Genomics Completes Acquisition of MC Diagnostics | digitalmedianet.com | ... an automated low density array platform (“ALDAS”), which is currently providing proven clinical diagnostic assays in the fields of HLA typing and blood group diagnostics.Revolutionary Breakthrough in Genechip TechnologyEffective and affordable cancer diagnostics testing tools with quick turnaround time and high sensitivity have always been sought after in the market. As a company at the forefront of Next Generation Sequencing (NGS) molecular diagnostics in the field of ... |
| 6/21/2021 | Immunohistochemistry/IHC Market worth $2.7 billion by 2025 | express-press-release.net | ... in the IHC market Based on diseases, the d iagnostic applications is further segmented into infectious diseases, cancer, autoimmune diseases, neurology, nephrological diseases, and other diseases (cardiovascular diseases, ophthalmology, and diabetes). In 2019, the cancer diagnostics segment accounted for the largest share of the immunohistochemistry market for diagnostic applications Growing use of IHC tests for cancer diagostics and increasing prevalence & incidence of cancer to fuel market growth. Hospitals & diagnostic laboratories ... |